Affymetrix and Applied Biosystems Enter into Licensing Agreement
News Dec 26, 2005
Affymetrix, Inc. and Applied Biosystems Group, an Applera Corporation business, have announced that Applera has taken a non-exclusive, worldwide license to a number of Affymetrix patents related to the manufacture, sale, and use of microarrays for gene expression analysis.
The license will be applied to the continued expansion of the Applied Biosystems Expression Array System for high density microarray analysis and will enable customers to use that system for gene expression, research and development purposes.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE